Join Host Michael Lerner with the CancerChoices team for a webinar conversation about the surprisingly good evidence of effectiveness for improving survival and reducing risk of cancer for three complementary therapies: aspirin, vitamin D, and melatonin.
The post Nancy Hepp, Laura Pole, and Host Michael Lerner appeared first on The New School at Commonweal.